首页>
外国专利>
SCD40L, PAPP-A and placental growth factor (PlGF) as a combination of biochemical markers in cardiovascular disease
SCD40L, PAPP-A and placental growth factor (PlGF) as a combination of biochemical markers in cardiovascular disease
展开▼
机译:SCD40L,PAPP-A和胎盘生长因子(PlGF)作为心血管疾病中生化指标的组合
展开▼
页面导航
摘要
著录项
相似文献
摘要
Analysis of samples associated with acute cardiovascular disease by determining the concentration of at least one of the markers soluble CD40 ligand (sCD40L); PAPP-A (pregnancy-associated plasma protein-A) and placental growth factor (PlGF), and comparing the result with reference values or results from reference samples. Analysis of samples associated with acute cardiovascular disease by determining the concentration of at least one of the markers soluble CD40 ligand (sCD40L); PAPP-A (pregnancy-associated plasma protein-A) and placental growth factor (PlGF), and comparing the result with reference values or results from reference samples. Optionally at least one of the additional markers troponin T (TnT), MPO (not defined), NT-pro-BNP (brain natriuretic peptide), VEGF (vascular endothelial growth factor), BNP or additional inflammation markers are also determined and compared. An independent claim is also included for a diagnostic kit comprising reagents for performing the new method, optionally also other components and/or auxiliaries.
展开▼